FDA inspection
No Miss Ltd., Inc.: FDA inspection ending Nov 29, 2007
FDA inspection 499325 · Official Action Indicated (OAI) · Boca Raton, FL
Key facts
| Inspection ID | 499325 |
|---|---|
| Firm | No Miss Ltd., Inc. |
| FEI number | 1000113136 |
| Address | 6401 E Rogers Cir |
| City | Boca Raton |
| State | FL |
| ZIP | 33487-2602 |
| Fiscal year | 2008 |
| Inspection end date | Nov 29, 2007 |
| Classification | Official Action Indicated (OAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs |
| Product type | Drugs, Food/Cosmetics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data